EUVIMED · CrossrefZeitschrift
Zeitschrift für Immunitätsforschung: Immunobiology
ISSN 0340-904X · Elsevier BV
Neueste Artikel
Symposium 1: Immunoendocrinology
Symposium 2: Effector Mechanism
Workshop No. 1: Ontogeny and Phylogeny of Immunity
Workshop No. 2: Clinical Relevance of New Immunological Methods
Workshop No. 3: Cellular Effector Mechanisms of Immunity
Workshop No. 4: Lymphocyte Subpopulations
Workshop No. 5: Production and Characterization of Monoclonal Antibodies
Workshop No. 6: Histocompatibility - Disease
Workshop No. 7: Complement
Workshop No. 8: Self Recognition - Physiology and Pathology
Workshop No. 9: Macrophages
Workshop No. 10: Tumor Immunology
Workshop No. 11: Clinical Slide Presentation
Workshop No. 12: Free Posters
Author's Index
Cellular and Humoral Adjuvant Activity of A Mistletoe Extract
Correlation between Effector Lymphocytes in Natural and Antibody-mediated Cytotoxicity
Editorial Board
Editorial Comment
Hypothesis on the Origin of the Strong Alloreactivity
Induction of Antibody Responses In Vivo by Antigen Specific Helper Factor
Cation Requirement of Natural, In-Vitro Generated and Antibody Dependent Killing Exerted by Human Lymphocytes
Light Chain Heterogeneity of Type λ Anti-Streptococcal Group A-variant Polysaccharide Antibodies in Rabbits
Establishment of A Human Lymphoblastoid Cell Line with Specific Antibody Production Against Group A Streptococcal Carbohydrate
Isolation of Type-Specific Antibody to Streptococcus Pyogenes by Affinity Chromatography
Interaction of Wheat-germ Agglutinin with Streptococci and Streptococcal Cell Wall Polymers
Studies of the Producer Cell of Interferon in Human Lymphocyte Cultures
Serological Studies on the Antigenic Relationship between Herpes Simplex Virus and Varicella-Zoster Virus
Generation of Virus Specific Cytotoxic T Cells In Vitro. III. Spleen Cells Stimulated by Viral Antigens Generate Alloreactive Cytotoxic T Cells
Generation of Effector Cells from T Cell Subsets. I. Similar Requirements for Lyt T Cell Subpopulations in the Generation of Alloreactive and H-2 Restricted Killer Cells
EUVIMED